Click on a filter below to refine your search. Remove a filter to broaden your search.
The authors urge greater transparency of study results for drugs approved by the FDA.
More inappropriate use was seen particularly for nursing homes in severely deprived neighborhoods.
An individual patient data meta-analysis shows increased risk for dementia for those with untreated hypertension.
Polypharmacy was tied to an increased risk for adverse treatment outcomes, such as toxicity and early treatment discontinuation.
Findings seen over three years in adults with preexisting cardiovascular disease and overweight or obesity
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
A significant reduction was seen in systolic blood pressure with zilebesiran 150, 300 or 600 mg once in six months and 300 mg once every three months.
Patients receiving mental health treatment were less likely to be rehospitalized, have an emergency department visit or die from any cause.
One-third of those say their lives were disrupted by the overdose death.
Nurse practitioners were overrepresented among clinicians with the highest and lowest rates of inappropriate prescribing.